Skip to Main Content
Skip Nav Destination

Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for β-blocker selection

Clin Sci (Lond) (2003) 105 (4): 507–512.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Yu. V. Ovchinnikov
  • M. B. Patsenko
  • N. I. Gulyaev
  • M. A. Lebedev
Clinical Medicine (Russian Journal) (2023) 101 (4-5): 181.
  • Natalie K. Binder
  • Teresa M. MacDonald
  • Sally A. Beard
  • Natasha de Alwis
  • Stephen Tong
  • Tu’uhevaha J. Kaitu’u-Lino
  • Natalie J. Hannan
Journal of Clinical Medicine (2021) 10 (15): 3384.
  • Chiman Salehi
  • Monireh Seiiedy
  • Hamid Soraya
  • Farzaneh Fazli
  • Morteza Ghasemnejad-Berenji
Naunyn-Schmiedeberg's Archives of Pharmacology (2021) 394 (4): 685.
  • Kurt Boman
  • Jan-Håkan Jansson
  • Torbjörn Nilsson
  • Karl Swedberg
  • John G.F. Cleland
  • Philip Poole-Wilson
Thrombosis Research (2010) 125 (2): e46.
  • Gurbir S. Bhatia
  • Michael D. Sosin
  • Jeetesh V. Patel
  • Karl A. Grindulis
  • Fazal H. Khattak
  • Russell C. Davis
  • Gregory Y.H. Lip
International Journal of Cardiology (2009) 134 (1): 97.
  • Paresh Dandona
  • Husam Ghanim
  • David P Brooks
Journal of Hypertension (2007) 25 (4): 731.
  • Bagher Larijani
  • Mojgan Afshari
  • Fatemeh Astanehi-Asghari
  • Alireza Mojtahedi
  • Ali Rezaie
  • Arash Hosseinnezhad
  • Ramin Heshmat
  • Azadeh Mohammadirad
  • Mohammad Abdollahi
Therapy (2006) 3 (1): 119.
  • Bagher Larijani
  • Mojgan Afshari
  • Fatemeh Astanehi-Asghari
  • Alireza Mojtahedi
  • Ali Rezaie
  • Arash Hosseinnezhad
  • Ramin Heshmat
  • Azadeh Mohammadirad
  • Mohammad Abdollahi
Therapy (2006) 3 (1): 119.
  • E. M. Stuveling
  • S. J. L. Bakker
  • H. L. Hillege
  • P. E. de Jong
  • R. O. B. Gans
  • D. de Zeeuw
Nephrology Dialysis Transplantation (2005) 20 (3): 497.
  • Lawrence S. Cozma
Current Opinion in Lipidology (2004) 15 (3): 369.
Close Modal

or Create an Account

Close Modal
Close Modal